Amgen Inc. (AMGN) Social Stream



Amgen Inc. (AMGN): $269.55

2.99 (-1.10%)

POWR Rating

Component Grades

Momentum

D

Stability

B

Sentiment

Quality

A

Add AMGN to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#17 of 345

in industry

AMGEN INC (AMGN) Price Targets From Analysts

Use the tables below to see what analysts covering AMGEN INC think about its future price and what recommendations they have for investors and traders.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-04 18 $298 $185 $242.866 $262.82 -7.59%
2021-11-19 19 $298 $185 $241.937 $262.82 -7.95%
2021-11-22 20 $298 $185 $239.117 $262.82 -9.02%
2021-12-20 21 $298 $185 $237.5 $262.82 -9.63%
2021-12-22 20 $298 $185 $237.888 $262.82 -9.49%
2022-01-04 19 $298 $185 $237.888 $262.82 -9.49%
2022-01-07 19 $298 $185 $235.611 $262.82 -10.35%
2022-01-18 18 $298 $185 $236.764 $262.82 -9.91%
2022-01-28 18 $298 $185 $237.411 $262.82 -9.67%
2022-02-08 18 $298 $194 $239.875 $262.82 -8.73%
2022-03-18 18 $298 $194 $246.125 $262.82 -6.35%
2022-04-12 17 $286 $194 $242.8 $262.82 -7.62%
2022-04-26 17 $295 $194 $243.8 $262.82 -7.24%
2022-04-29 15 $295 $194 $247.571 $262.82 -5.8%
2022-05-10 16 $295 $208 $248.785 $262.82 -5.34%
2022-05-23 16 $295 $208 $249.266 $262.82 -5.16%
2022-05-31 16 $295 $208 $249.6 $262.82 -5.03%
2022-06-15 16 $295 $208 $249.933 $262.82 -4.9%
2022-07-25 16 $295 $208 $252.571 $262.82 -3.9%
2022-08-03 16 $295 $208 $250.866 $262.82 -4.55%
2022-08-05 17 $295 $208 $250.866 $262.82 -4.55%
2022-08-08 17 $295 $208 $252.666 $262.82 -3.86%
2022-09-17 18 $295 $182 $248.25 $262.82 -5.54%
2022-10-03 18 $295 $182 $250.133 $262.82 -4.83%
2022-10-11 18 $295 $182 $251.6 $262.82 -4.27%
2022-10-21 18 $295 $182 $251.466 $262.82 -4.32%
2022-10-24 18 $295 $182 $254 $262.82 -3.36%
2022-11-02 18 $295 $182 $254 $262.82 -3.36%
2022-11-03 17 $295 $182 $254 $262.82 -3.36%
2022-11-04 17 $300 $182 $256.666 $262.82 -2.34%
2022-11-08 16 $325 $182 $261.333 $262.82 -0.57%
2022-12-04 13 $325 $182 $259.461 $262.82 -1.28%
2022-12-07 13 $325 $182 $260.23 $262.82 -0.99%
2022-12-12 12 $325 $182 $261.692 $262.82 -0.43%
2022-12-14 12 $325 $182 $262 $262.82 -0.31%
2022-12-22 12 $325 $182 $264 $262.82 0.45%
2023-01-19 13 $325 $182 $266.23 $262.82 1.3%
2023-01-27 13 $325 $182 $266.692 $262.82 1.47%
2023-02-01 14 $325 $182 $267.461 $262.82 1.77%
2023-02-02 14 $325 $182 $263.384 $262.82 0.21%
2023-02-12 14 $325 $182 $261.846 $262.82 -0.37%
2023-02-27 14 $325 $182 $261.692 $262.82 -0.43%
2023-04-04 14 $325 $182 $260.923 $262.82 -0.72%
2023-04-16 15 $325 $182 $260.923 $262.82 -0.72%
2023-04-28 15 $325 $182 $260.538 $262.82 -0.87%
2023-05-01 15 $325 $182 $259.23 $262.82 -1.37%
2023-05-02 15 $325 $182 $259.692 $262.82 -1.19%
2023-05-17 16 $325 $182 $259.384 $262.82 -1.31%
2023-07-09 16 $289 $182 $255.538 $262.82 -2.77%
2023-08-04 16 $289 $182 $254.384 $262.82 -3.21%
2023-08-11 15 $293 $210 $261.416 $262.82 -0.53%
2023-08-14 15 $310 $210 $264.333 $262.82 0.58%
2023-08-16 16 $310 $185 $258.23 $262.82 -1.75%
2023-09-26 16 $320 $185 $262.642 $262.82 -0.07%
2023-10-02 16 $320 $185 $264.071 $262.82 0.48%
2023-10-09 17 $320 $185 $264.785 $262.82 0.75%
2023-10-13 17 $320 $185 $269.857 $262.82 2.68%
2023-10-17 18 $320 $185 $275.533 $262.82 4.84%
2023-10-19 19 $320 $185 $276.2 $262.82 5.09%
2023-10-25 19 $320 $185 $275.812 $262.82 4.94%
2023-10-26 19 $336 $185 $279.125 $262.82 6.2%
2023-10-31 19 $336 $185 $278.562 $262.82 5.99%
2023-11-03 20 $336 $185 $281.47 $262.82 7.1%
2023-11-20 21 $336 $185 $279.333 $262.82 6.28%

The Trend in the Analyst Price Target


AMGN's average price target has moved up $26.87 over the prior 42 months.

AMGN reports an average of 3.42% for its upside potential over the past 50 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2022-12-14 12 325 182 262.000 271.13 -3.37%
2023-04-16 15 325 182 260.692 250.00 4.28%
2023-04-16 15 325 182 260.923 250.00 4.37%
2023-08-04 15 289 210 260.333 243.28 7.01%
2023-08-14 15 310 210 264.333 260.97 1.29%

AMGN Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
2.43 8 0 11 2 2 21

The Trend in the Broker Recommendations


Over the past 20 months, AMGN's average broker recommendation rating improved by 0.22.

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for AMGN as an investment opportunity.

  • AMGEN INC's average analyst price target is greater than 7514.11% of all US stocks.
  • AMGEN INC's upside potential (average analyst target price relative to current price) is greater than 562.41% of Pharmaceutical Products stocks.
  • AMGN has a higher number of analysts covering the stock than 7302.04% of Pharmaceutical Products stocks.
  • To contextualize these metrics, consider that out of Pharmaceutical Products stocks, AMGEN INC's variance in analysts' estimates is lower than -2448.24% of them.

In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to AMGEN INC are DNA, CGC, and TLRY.

Make investment decisions regarding AMGN using the data that counts. Try POWR Ratings for free.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!